NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 0.5240
-0.0360 (-6.43%)
Oct 23, 2026, 10:09 AM CEST
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €6.64 million as of October 22, 2026. It is the 42,701st most valuable company in the world and the 563rd biggest in France. Its market cap has decreased by 55.21% in one year.
Market Cap
6.64M
Enterprise Value
5.02M
Revenue
188.00
Global Rank
Country Rank
#563 France
PE Ratio
n/a
ChartMarket Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 6.64M, a decrease of -65.90%. That is a compound annual growth rate of -18.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 6.64M | -55.52% |
| Dec 31, 2025 | 14.93M | -21.92% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
| Jul 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 20.47M |
| GenSight Biologics | 17.21M |
| Biophytis | 11.90M |
| TME Pharma | 10.80M |
| Poxel | 10.58M |
| Aton | 10.27M |
| Aelis Farma | 9.79M |
| Advicenne | 9.31M |